Almohanad A. Alkayyal
Tabuk, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation.
Journal: Frontiers in oncology
Published: March 05, 2026
Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 24, 2026
Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD-Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses.
Journal: Vaccines
Published: November 14, 2025
Harnessing SARS-CoV-2 immunity to promote antitumor responses through intratumoral vaccination and adoptive transfer.
Journal: Frontiers in immunology
Published: September 23, 2025
Tumor-directed evolution of VSVΔ51M produces novel viruses with enhanced antitumor efficacy.
Journal: Frontiers in molecular biosciences
Published: June 29, 2025
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology.
Journal: Frontiers in molecular biosciences
Published: April 21, 2025
Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapy.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: March 10, 2025
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 04, 2024
Construction of VSVΔ51M oncolytic virus expressing human interleukin-12.
Journal: Frontiers in molecular biosciences
Published: March 21, 2023
Association of Genetic and Allelic Variants of Von Willebrand Factor (VWF), Glutathione S-Transferase and Tumor Necrosis Factor Alpha with Ischemic Stroke Susceptibility and Progression in the Saudi Population.
Journal: Life (Basel, Switzerland)
Published: March 09, 2023
Last Updated: 09/26/2026